Chemopreventive effect of M2000, a new anti-inflammatory agent

Medical Science Monitor

Volumn 10, Issue 10, 2004, Pages

  Mirshafiey, Abbas ^a   Khorramizadeh, Mohammad Reza ^a   Saadat, Farshid ^a   Rehm, Bernd H A ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Angiopathogenesis; Apoptosis; Cancer; Matrix metalloproteinases

Indexed keywords

DEXAMETHASONE; DICLOFENAC; GELATIN; GELATINASE A; M 2000; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER PREVENTION; CANCER RISK; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME ACTIVITY; FIBROSARCOMA; IN VITRO STUDY; MOUSE; NICK END LABELING; NONHUMAN; ZYMOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; FIBROSARCOMA; HYDROCARBONS; MATRIX METALLOPROTEINASE 2; MICE;

EID: 7044249213     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rhoda Lee C, Balfour JA: Piroxicam-β-Cyclodextrin, A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states. Drugs, 1994; 48: 907-29
2. Abramson S, Weissmann G: The mechanism of action of nonsteroidal anti-inflammatory drugs. Clin Exp Rheumatol, 1989; 7 Suppl: 163-70
3. Gomez-Gaviro MV, Gonzalez-Alvaro I, Dominguez-Jimenez C et al: Structure-function relationship and role of tumor necrosis factor-alpha- converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. J Biol Chem, 2002; 277: 38212-21
4. Vignon E, Mathieu F, Louisot P et al: In vitro effect of nonsteroidal anti-inflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage. Arthritis Rheum,1991; 34: 1332-35
5. Sopata I, Wojtecka-Luksik E, Maslinski S: Auranofin modulates gelatinase release from rat neutrophils. Int J Tissue React, 1987; 9: 471-76
6. Sanchez C, Matens MM, Defresne MP: Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1 beta and nonsteroidal anti-inflammatory drugs. J Rheumatol. 2002; 29: 772-82
7. Peleg H, Maibach HT, Brown SH et al: Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med, 1994; 154: 394-99
8. Muscat JE, Stellman SD, Wynder EL: Nonsteroidal anti-inflammatory drugs and colorectal cancer. Cancer, 1994; 74: 1847-54
9. González-Pérez A, Rodríguez LAG, López-Ridaura R: Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer, 2003; 3: 28
10. Rosenberg L, Palmer JR, Zauber AG et al: A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst, 1991; 83: 355-58
11. Farrow DC, Vaughan TL, Hansten PD et al: Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev, 1998; 7: 97-102
12. Langman MJ, Cheng KK, Gilman EA et al: Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ, 2000; 320: 1642-46
13. Li M, Lotan R, Levin B et al: Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomarkers Prev, 2000; 9: 545-49
14. Lehnert T, Deschner EE, Karmali RA et al: Effect of fhurbiprofen and 16,16-dimethyl-prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats. I. Squamous epithelium and mesenchymal tissue. J Natl Cancer Inst, 1987; 78: 923-29
15. Shibata MA, Hirose M, Masuda A et al: Modification of BHA forestomach carcinogenesis in rats: inhibition by diethylmaleate or indomethacin and enhancement by a retinoid. Carcinogenesis, 1993; 14: 1265-69
16. Pollard M, Lnckert PH: Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. J Natl Cancer Inst, 1983; 70: 1103-5
17. Takahashi M, Furukawa F, Toyoda K et al: Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis, 1990; 11: 393-95
18. Jalbert G, Castonguay A: Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett, 1992; 66: 21-28
19. Lala PK, Al-Mutter N, Orucevic A: Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer, 1997; 73: 371-80
20. Robertson FM, Parrett ML, Joarder FS et al: Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett, 1998; 122: 165-75.
21. Liu XH, Kirschenbaum A, Yao S et al: Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol, 2000; 164: 820-25
22. Stetler-Stevenson WG, Hewitt R, Corcoran M: Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol, 1996; 7: 147-54
23. Jones L, Ghaneh P, Humphreys M et al: The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann New York Acad Sci, 1999: 880: 288-307
24. John A, Tuszynski G: The role of matrix metalloproteinase in tumor angiogenesis and tumor metastasis. Pathol Oncol Res, 2001; 7: 14-23
25. Nguyen M, Arkell J, Jackson CJ: Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol, 2001; 33: 960-70
26. Qiu ZF, Maruyama K, Sunayama K et al: Piroxicam-induced regression of intestinal adenomatous polyps in APC (delta 474) mice. J Invest Surg, 2003; 16: 71-81
27. Elder DJE, Halton DE, Hague A et al: Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res. 1997; 3: 1679-83
28. Soini Y, Satta J, Maatta M et al: Expression of MMP2, MMP9, MTI-MMP, TIMPI, and TIMP2 mRNA in valvular lesions of the heart. J Pathol. 2001; 194: 225-31
29. Peterson M, Porter KE, Loftus IM et al: Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia. Eur J Vasc Endovasc Surg, 2000; 19: 461-67
30. Porter KE, Loftus IM, Peterson M et al: Marimastat inhibits neointimal thickening in a model of human vein graft stenosis. Br J Surg, 1998; 85: 1373-77
31. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activator in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem, 1980; 102: 196-202
32. Mohammed SI, Bennett PF, Craig BA et al: Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res, 2002; 62: 356-58
33. Chan AT: Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet, 2002; 3: 166-74
34. Smith ML, Hawcroft G, Hull MA: The effect of nonsteroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer, 2000; 36: 664-74
35. Waddell WR: Stimulation of apoptosis by sulindac and piroxicam. Clin Sci (Lond), 1998; 95: 385-88
36. Pross C, Farooq MM, Angle N et al: Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity. J Surg Res, 2002; 102: 57-62